SCHEMBL30767880

SCHEMBL30767880

Cc1cc(=O)oc2cc(CC(=O)O)ccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA9 Q16790 4/20 0.59
▸ CA1 P00915 3/20 0.59
▸ CA2 P00918 1/20 0.59
▸ CA5A P35218 1/20 0.59
▸ ALDH1A1 P00352 11/20 0.58
▸ KDM4E B2RXH2 10/20 0.58
▸ HPGD P15428 9/20 0.58
▸ HSD17B10 Q99714 7/20 0.58
▸ GLA P06280 6/20 0.58
▸ GAA P10253 5/20 0.58
▸ CA12 O43570 3/20 0.58
▸ CASP1 P29466 3/20 0.58
▸ CASP7 P55210 3/20 0.58
▸ MAOB P27338 2/20 0.58
▸ AKR1B1 P15121 2/20 0.58
▸ LMNA P02545 1/20 0.58
▸ CYP1A2 P05177 1/20 0.58
▸ CYP2C9 P11712 1/20 0.58
▸ UGT1A1 P22309 1/20 0.58
▸ KDR P35968 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3250182 1.00 CA9 (0.59) CA9CA1CA2CA5AALDH1A1
SCHEMBL8515319 0.87 CA9 (0.62) CA9CA1CA2CA5AALDH1A1
SCHEMBL15924043 0.86 KDM4E (0.53) ALDH1A1KDM4EHPGDHSD17B10GLA
SCHEMBL4609492 0.85 KDM4E (0.61) CA9CA1CA2CA5AALDH1A1
SCHEMBL1362612 0.83 ALDH1A1 (0.62) CA9CA1CA2CA5AALDH1A1
SCHEMBL17358708 0.83 CA9 (0.64) CA9CA1CA2CA5AALDH1A1
SCHEMBL31710481 0.83 KCNA3 (0.52) CA9ALDH1A1KDM4EHPGDCA12
SCHEMBL27780809 0.82 AKR1B1 (0.49) CA9CA1CA2CA5AALDH1A1
SCHEMBL10709372 0.82 ALDH1A1 (0.61) CA9CA1CA2CA5AALDH1A1
SCHEMBL4609859 0.81 ALDH1A1 (0.60) CA9CA1CA2CA5AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4316495-A1 NUCLEIC ACID MOLECULE CONJUGATE HAVING PROLONGED IN VIVO HALF-LIFE Aptacure Therapeutics Limited (HK) 2024-02-07 — — EP claimed
CN-122094697-A Aptamer conjugates for targeted degradation of osteopetron — 2026-05-26 — — CN disclosed
CN-117916377-A Aptamer for DKK1 and use thereof 安沛治疗有限公司 2024-04-19 — — CN disclosed
EP-4316495-A1 NUCLEIC ACID MOLECULE CONJUGATE HAVING PROLONGED IN VIVO HALF-LIFE Aptacure Therapeutics Limited (HK) 2024-02-07 — — EP disclosed
Send feedback